Imatinib, a tyrosine kinase inhibitor, is widely used for treating gastrointestinal stromal tumors (GISTs) and chronic myeloid leukemia (CML). While commonly associated with mild fluid retention, significant pleural effusion is an uncommon but potentially serious adverse effect. We present a case of...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!